Bioxodes
Charleroi, BE· latest recorded location
BIOXODES is named on 4 US grants and 8 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 4
- Published applications
- 8
- Inventors
- 10
- Granted in 2026 so far
- 1
- Most recent grant
- 10 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2015 | 2 | 0 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 1 | 2 |
| 2025 | 0 | 2 |
| 2026 | 1 | 1 |
By publication year. 2026 runs to 8 Oct.
Technology areas
Share of 12 documents
Recent patents
- Methods for preventing and treating brain inflammation10 Feb 2026US 12,544,425 B2
- Anticoagulant fusion proteins and uses thereof13 Feb 2024US 11,897,924 B2
- Identification and molecular characterisation of proteins, expressed in the Ixodes ricinus salivary glands15 Dec 2015US 9,212,216 B2
- Identification and molecular characterisation of proteins, expressed in the Ixodes ricinus salivary glands27 Oct 2015US 9,169,314 B2
- Methods for preventing and treating brain inflammation14 May 2026US 2026/0130969 A1
- Anticoagulant proteins and their use for treating diseases associated with the activation of neutrophils25 Sep 2025US 2025/0295734 A1
- Methods for preventing and treating brain inflammation13 Mar 2025US 2025/0082725 A1
- Anticoagulant proteins and their use for treating diseases associated with the activation of neutrophils16 May 2024US 2024/0156906 A1
- Anticoagulant fusion proteins and uses thereof18 Apr 2024US 2024/0124534 A1
Most cited
By later US patents
- Anticoagulant fusion proteins and uses thereof1US 11,897,924 B22024
- Identification and molecular characterisation of proteins, expressed in the Ixodes ricinus salivary glands1US 9,169,314 B22015
- Identification and molecular characterisation of proteins, expressed in the Ixodes ricinus salivary glands1US 9,212,216 B22015